Search Results Search Sort by RelevanceMost Recent State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687. State of the Art and Science Sep 2017 Swift and Certain, Proportionate and Consistent: Key Values of Urine Drug Test Consequences for Probationers Amy B. Cadwallader, PhD Probation programs that use a frequent, random urine drug testing (UDT) coupled with swift consequences for violations reduce drug use and recidivism. AMA J Ethics. 2017;19(9):931-938. doi: 10.1001/journalofethics.2017.19.9.stas2-1709. State of the Art and Science Sep 2017 Why It’s Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy Sarah E. Wakeman, MD Although effective, opioid agonist therapy is associated with stigma and thus underutilized for treatment of opioid use disorder in incarcerated settings. AMA J Ethics. 2017;19(9):922-930. doi: 10.1001/journalofethics.2017.19.9.stas1-1709.
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
State of the Art and Science Sep 2017 Swift and Certain, Proportionate and Consistent: Key Values of Urine Drug Test Consequences for Probationers Amy B. Cadwallader, PhD Probation programs that use a frequent, random urine drug testing (UDT) coupled with swift consequences for violations reduce drug use and recidivism. AMA J Ethics. 2017;19(9):931-938. doi: 10.1001/journalofethics.2017.19.9.stas2-1709.
State of the Art and Science Sep 2017 Why It’s Inappropriate Not to Treat Incarcerated Patients with Opioid Agonist Therapy Sarah E. Wakeman, MD Although effective, opioid agonist therapy is associated with stigma and thus underutilized for treatment of opioid use disorder in incarcerated settings. AMA J Ethics. 2017;19(9):922-930. doi: 10.1001/journalofethics.2017.19.9.stas1-1709.